RenalGuard Solutions, Inc.
459 Fortune Boulevard
Milford
Massachusetts
01757
United States
Tel: 508-541-8800
Website: http://www.renalguard.com
Email: info@renalguard.com
About RenalGuard Solutions, Inc.
Headquartered in Milford, Massachusetts, RenalGuard Solutions, Inc. is a medical device company focused on innovative technologies for the cardiac and vascular markets.LEADERSHIP:
CBO and CFO: Gregory W. Mann
FOLLOW RENALGUARD SOLUTIONS:
Tweets by RenalGuard Solutions
7 articles about RenalGuard Solutions, Inc.
-
Late-Breaking REMEDIAL III Clinical Trial Presented at TCT Shows RenalGuard Therapy's Automated, Personalized Hydration Superior in Preventing Contrast-Induced Acute Kidney Injury
10/3/2019
RenalGuard Solutions™, a pioneering medical device company focused on protecting patients from acute kidney injury (AKI), announced today that a late-breaking clinical trial found the company's RenalGuard Therapy® superior to the POSEIDON method in preventing contrast-induced acute kidney injury (CI-AKI) for patients with kidney disease who undergo interventional procedures
-
RenalGuard Solutions Reaches Milestone of 20,000 Patients Treated with RenalGuard
8/22/2018
RenalGuard Therapy Continues to Demonstrate Effectiveness for the Prevention of Acute Kidney Injury in High-Risk Patients
-
New Study Demonstrates Feasibility of Using RenalGuard-Guided Diuretic Therapy for Acute Heart Failure Patients
5/29/2018
RenalGuard Solutions™, Inc. announced new clinical study results demonstrating the feasibility of using RenalGuard®-Guided Diuretic Therapy.
-
RenalGuard Solutions Announces Appointment of Dr. Howard R. Levin as Chief Medical Officer
5/15/2018
Dr. Levin Brings More Than 35 Years of Biomedical Engineering and Cardiac Expertise to the Company
-
RenalGuard System Demonstrates Promising Results from First-in-Man Studies to Evaluate Technology for Heart Failure Patients
1/2/2018
RenalGuard Solutions today reported positive results from a first-in-man feasibility study focusing on a novel use of the RenalGuard System to manage fluids during diuretic therapy in congestive heart failure patients suffering from fluid overload.
-
RenalGuard Names Former St. Jude Medical-Abiomed Exec as New CEO
7/10/2017
-
Massachusetts' RenalGuard Grabs $15 Million Series A
3/16/2017